Skip to main content
Thorax logoLink to Thorax
. 2001 Apr;56(4):266–271. doi: 10.1136/thorax.56.4.266

Relationship between anxiety, depression, and morbidity in adult asthma patients

L Rimington 1, D Davies 1, D Lowe 1, M Pearson 1
PMCID: PMC1746028  PMID: 11254816

Abstract

BACKGROUND—Symptoms of disease reported by patients reflect the effects of the disease process within the individual and the person's physical and mental ability to tolerate or otherwise cope with the limitations on their functioning. This study examines the relationship between asthma symptoms, disease severity, and psychological status in patients being managed in routine primary healthcare settings.
METHODS—One hundred and fourteen subjects from four GP practices, two inner city and two suburban, were studied. Symptoms were assessed by means of the Asthma Quality of Life questionnaire (AQLQ) and a locally devised Q score, and psychological status with the Hospital Anxiety and Depression (HAD) scale. Spirometric values and details of current asthma treatment (BTS asthma guidelines treatment step) were recorded as markers of asthma severity.
RESULTS—Symptoms as measured by AQLQ correlated with peak expiratory flow (rS = 0.40) and with BTS guidelines treatment step (rS =0.25). Similarly, the Q score correlated with peak expiratory flow (rS = 0.44) and with BTS guidelines treatment step (rS =0.42). Similar levels of correlation of forced expiratory volume in one second (FEV1) with symptoms were reported. HAD anxiety and depression scores also correlated to a similar extent with these two symptom scores, but there was hardly any correlation with lung function. Logistic regression analysis showed that HAD scores help to explain symptom scores over and above the effects of lung function and BTS guidelines treatment step. Symptoms, depression, and anxiety were higher for inner city patients while little difference was observed in objective measures of asthma.
CONCLUSIONS—Asthma guidelines suggest that changing levels of symptoms should be used to monitor the effectiveness of treatment. These data suggest that reported symptoms may be misleading and unreliable because they may reflect non-asthma factors that cannot be expected to respond to changes in asthma treatment.



Full Text

The Full Text of this article is available as a PDF (148.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosley C. M., Corden Z. M., Cochrane G. M. Psychosocial factors and asthma. Respir Med. 1996 Sep;90(8):453–457. doi: 10.1016/s0954-6111(96)90170-5. [DOI] [PubMed] [Google Scholar]
  2. Connolly C. K., Prescott R. J., Alcock S. M., Gatnash A. A. Actual over best function as an outcome measure in asthma. Respir Med. 1994 Jul;88(6):453–459. doi: 10.1016/s0954-6111(05)80049-6. [DOI] [PubMed] [Google Scholar]
  3. Dales R. E., Spitzer W. O., Schechter M. T., Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis. 1989 Jun;139(6):1459–1463. doi: 10.1164/ajrccm/139.6.1459. [DOI] [PubMed] [Google Scholar]
  4. Gruffydd-Jones K. Quality-of-life measures in asthma--do they matter to the GP? Br J Gen Pract. 1997 Jun;47(419):392–394. [PMC free article] [PubMed] [Google Scholar]
  5. Horn C. R., Clark T. J., Cochrane G. M. Compliance with inhaled therapy and morbidity from asthma. Respir Med. 1990 Jan;84(1):67–70. doi: 10.1016/s0954-6111(08)80097-2. [DOI] [PubMed] [Google Scholar]
  6. Huey S. R., West S. G. Hyperventilation: its relation to symptom experience and to anxiety. J Abnorm Psychol. 1983 Nov;92(4):422–432. doi: 10.1037//0021-843x.92.4.422. [DOI] [PubMed] [Google Scholar]
  7. Innes N. J., Reid A., Halstead J., Watkin S. W., Harrison B. D. Psychosocial risk factors in near-fatal asthma and in asthma deaths. J R Coll Physicians Lond. 1998 Sep-Oct;32(5):430–434. [PMC free article] [PubMed] [Google Scholar]
  8. Janson C., Björnsson E., Hetta J., Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):930–934. doi: 10.1164/ajrccm.149.4.8143058. [DOI] [PubMed] [Google Scholar]
  9. Jarman B. Identification of underprivileged areas. Br Med J (Clin Res Ed) 1983 May 28;286(6379):1705–1709. doi: 10.1136/bmj.286.6379.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones P. W. Quality of life measurement in asthma. Eur Respir J. 1995 Jun;8(6):885–887. [PubMed] [Google Scholar]
  11. Juniper E. F., Guyatt G. H., Ferrie P. J., Griffith L. E. Measuring quality of life in asthma. Am Rev Respir Dis. 1993 Apr;147(4):832–838. doi: 10.1164/ajrccm/147.4.832. [DOI] [PubMed] [Google Scholar]
  12. Juniper E. F., Guyatt G. H., Willan A., Griffith L. E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994 Jan;47(1):81–87. doi: 10.1016/0895-4356(94)90036-1. [DOI] [PubMed] [Google Scholar]
  13. Juniper E. F., Johnston P. R., Borkhoff C. M., Guyatt G. H., Boulet L. P., Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med. 1995 Jan;151(1):66–70. doi: 10.1164/ajrccm.151.1.7812574. [DOI] [PubMed] [Google Scholar]
  14. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  15. Rand C. S., Wise R. A., Nides M., Simmons M. S., Bleecker E. R., Kusek J. W., Li V. C., Tashkin D. P. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992 Dec;146(6):1559–1564. doi: 10.1164/ajrccm/146.6.1559. [DOI] [PubMed] [Google Scholar]
  16. Somerville M., Williams E. M., Pearson M. G. Asthma deaths in Mersey region 1989-1990. J Public Health Med. 1995 Dec;17(4):397–403. [PubMed] [Google Scholar]
  17. Spence D. P., Johnston S. L., Calverley P. M., Dhillon P., Higgins C., Ramhamadany E., Turner S., Winning A., Winter J., Holgate S. T. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med. 1994 May;149(5):1142–1148. doi: 10.1164/ajrccm.149.5.8173754. [DOI] [PubMed] [Google Scholar]
  18. Yellowlees P. M., Kalucy R. S. Psychobiological aspects of asthma and the consequent research implications. Chest. 1990 Mar;97(3):628–634. doi: 10.1378/chest.97.3.628. [DOI] [PubMed] [Google Scholar]
  19. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES